Previous 10 | Next 10 |
Activists are circling the company and pressuring to unlock shareholder value. Stock still looks attractive from a valuation and near-term catalyst standpoint. We could see shares trade between $36 and $73 in the coming months. For further details see: Activist Spotlight...
In any market’s upswing, there are always going to be people who make the case that “it’s different this time”, and historically, most of the time, that argument doesn’t hold up. I have never seen so many interesting and novel therapeutic opportuniti...
According to the most recent healthcare report from the OECD, prescribed medicines here in the United States cost $1025.60 per capita, where the average per capita spending in the developed countries of the OECD is only $567.70. According to the same source, we spend $10,966 per capit...
rogerashford/iStock via Getty Images Statins, a popular class of cholesterol-lowering drugs, may also lower the risk of death from COVID-19, according to new findings. Examining data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, researchers at the Univ...
The best news last week was the continuing decline in global bond yields, including the 10-year Treasury rate falling below 1.4% last Tuesday. If and when the Fed decides to raise key short-term interest rates, I don’t think they will be able to raise rates by much, since the f...
krblokhin/iStock via Getty Images A new report from Democrats on the House Committee on Oversight and Reform says that pharmaceutical companies have spent more on stock buybacks and paying dividends to investors than on research and development. According to the documents, between 2016 and 20...
From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...
iShares U.S. Pharmaceuticals ETF (IHE) - $0.7206.30-Day SEC Yield of 1.36% as of May. 28.Payable Jun 16; for shareholders of record Jun 11; ex-div Jun 10. For further details see: iShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.7206
Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare
In January 2020, only 0.24% of total medical claims in the U.S. were telemedicine-related. One year later, they totaled 7%. It took 15 years for e-commerce penetration to rise from less than 1% to over 7%. The pandemic helped telemedicine do it in one. Population-wide immunity to ...
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Pharmaceutical Company Name:
IHE Stock Symbol:
NYSE Market:
2024-07-12 08:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-22 11:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-31 20:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...